| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/24/2010 | EP2157089A1 The therapeutic uses of imidazol-5-carboxylic acid derivatives |
| 02/24/2010 | EP2157082A1 Neurite formation promoter |
| 02/24/2010 | EP2156848A1 Low-molecule drug-containing nanoparticle having sustained release negatively charged group |
| 02/24/2010 | EP2156840A2 Use of mometasone furoate for treating airway passage and lung diseases |
| 02/24/2010 | EP2156838A1 Method for producing pharmaceutical tablet |
| 02/24/2010 | EP2156837A1 Crystalline micropowder particles |
| 02/24/2010 | EP2156832A1 Pharmaceutical composition |
| 02/24/2010 | EP2156827A1 Poultice and process for producing the poultice |
| 02/24/2010 | EP2156826A1 Microcapsule formulations comprising two pharmaceutically active ingredients |
| 02/24/2010 | EP2156825A1 Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses |
| 02/24/2010 | EP2156824A1 Composition of solifenacin or salt thereof for use in solid formulation |
| 02/24/2010 | EP2156823A1 Process for the preparation of sterile powdered pharmeceutical compounds in the form of micro and nanoparticles |
| 02/24/2010 | EP2156820A1 Skin whitening agent |
| 02/24/2010 | EP2155334A2 Controlled release oral formulations of ion channel modulating compounds and related methods for preventing arrhythmia |
| 02/24/2010 | EP2155261A1 Sensory feedback-based method for determining the bioavailability of orally administered dietary supplements |
| 02/24/2010 | EP2155252A1 Injectable polymer-lipid blend for localized drug delivery |
| 02/24/2010 | EP2155235A1 Oxygen-generating compositions for enhancing cell and tissue survival in vivo |
| 02/24/2010 | EP2155229A2 Composition for transmucosal delivery of polypeptides |
| 02/24/2010 | EP2155205A1 Treatment of meconium aspiration syndrome with estrogens |
| 02/24/2010 | EP2155176A2 Substrate promoting angiogenesis |
| 02/24/2010 | EP2155175A1 Matrix-type transdermal drug delivery system and preparation method thereof |
| 02/24/2010 | EP2155174A2 Uniformly abrasive confectionery product and process therefor |
| 02/24/2010 | EP2155173A1 Modified-release particles based on polyelectrolytes and on an active principle and pharmaceutical formulations containing these particles |
| 02/24/2010 | EP2155172A2 Gastroretentive system comprising an alginate body |
| 02/24/2010 | EP2155171A1 Osmotic form for controlled release of active principles |
| 02/24/2010 | EP2155170A2 Extended release formulation and method of treating adrenergic dysregulation |
| 02/24/2010 | EP2155169A2 Extended release formulation of nevirapine |
| 02/24/2010 | EP2155168A2 Stable pharmaceutical compositions of clopidogrel bisulfate and process of preparation thereof |
| 02/24/2010 | EP2155167A2 Controlled release pharmaceutical compositions for prolonged effect |
| 02/24/2010 | EP2155166A2 Pharmaceutical compositions for poorly soluble drugs |
| 02/24/2010 | EP2155165A1 Drug delivery vehicle containing vesicles in a hydrogel base |
| 02/24/2010 | EP2155164A1 Self-precipitating pharmaceutical formulations for the modified release of active principle |
| 02/24/2010 | EP2155163A1 Composition for injection including propofol and method of preparing the same |
| 02/24/2010 | EP2155161A2 Stable liquid composition of chondroitinsulfate and glucosamine |
| 02/24/2010 | EP2155159A2 Robust rapid disintegration tablet formulation |
| 02/24/2010 | EP2155158A1 Personal lubricant composition |
| 02/24/2010 | EP2155139A2 Pack of medicinal tablets |
| 02/24/2010 | EP1789057B1 Neuroprotective effect of solubilized udca in focal ischemic model |
| 02/24/2010 | EP1641438B1 Process for the preparation of the amorphous form of a drug |
| 02/24/2010 | EP1615615B1 Tamper-resistant products for opioid delivery |
| 02/24/2010 | EP1551505B1 Medical device for controlled drug delivery and cardiac monitoring and/or stimulation |
| 02/24/2010 | EP1471936B1 Hiv vaccine and method of use |
| 02/24/2010 | EP1007084B1 Immunogenic lhrh compositions and methods relating thereto |
| 02/24/2010 | CN201410117Y Medicated cake |
| 02/24/2010 | CN201410116Y Amoxicillin and sulbactam pivoxil dual-release capsule |
| 02/24/2010 | CN101657190A A biodegradable microsphere composition suitable for the controlled release of glucose controlling peptide and formulation thereof |
| 02/24/2010 | CN101657189A Convection enhanced delivery apparatus, method and application |
| 02/24/2010 | CN101657188A Solid pharmaceutical and vaccine dose |
| 02/24/2010 | CN101657187A Stable aqueous G-CSF formulations |
| 02/24/2010 | CN101657186A Granular material for dosage forms |
| 02/24/2010 | CN101657185A thixotropic pharmaceutical compositions |
| 02/24/2010 | CN101657184A Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use |
| 02/24/2010 | CN101654673A Rna interference mediating small rna molecules |
| 02/24/2010 | CN101654672A Rna interference mediating small rna molecules |
| 02/24/2010 | CN101654479A Mammalian receptor proteins, agents, and methods relating thereto |
| 02/24/2010 | CN101653431A Oral mucosa medicament slow release preparation for treating oral periodontal disease and preparation thereof |
| 02/24/2010 | CN101653430A Combined capsule filled with solid preparation of angiotensin II receptor antagonist and solid preparation of hydrochlorothiazide |
| 02/24/2010 | CN101653429A Method for preparing soft capsules by extracting alpha-linolenic acid from paeonia peony seeds |
| 02/24/2010 | CN101653428A Rifaximin enteric-coated preparation composition and preparation method thereof |
| 02/24/2010 | CN101653427A Coated vitamin C granules and preparation method thereof |
| 02/24/2010 | CN101653426A Slow release pellet of high-stability type cysteamine hydrochloride and preparation method thereof |
| 02/24/2010 | CN101653425A Arbidol hydrochloride medicament composition dispersible tablets and preparation method thereof |
| 02/24/2010 | CN101653424A 高药物载荷片剂 High drug load tablets |
| 02/24/2010 | CN101653423A Lacidipine tablets and preparation method thereof |
| 02/24/2010 | CN101653422A Risperidone slow-release microsphere, preparation method and application thereof |
| 02/24/2010 | CN101653421A Compositions comprising pectin and ascorbic acid |
| 02/24/2010 | CN101653420A Ultrasonically controlled-release target medicinal preparation and production method thereof |
| 02/24/2010 | CN101653419A Compound doxycycline hydrochloride soluble powder and preparation method thereof |
| 02/24/2010 | CN101653418A Soluble powder for treating canine ehrlichiosis and preparation method thereof |
| 02/24/2010 | CN101653417A Compound colistin sulfate soluble powder for treating lamb dysentery and preparation method thereof |
| 02/24/2010 | CN101653416A Tumor dual target liposome mediated by integrin and preparation method thereof |
| 02/24/2010 | CN101653415A Florfenicol liposome preparation and preparation method thereof |
| 02/24/2010 | CN101653414A Long-circulating solid lipid docetaxel nanoparticles and preparation method thereof |
| 02/24/2010 | CN101653413A Tacrolimus ophthalmic emulsion and its preparation method |
| 02/24/2010 | CN101653412A Stable rocuronium bromide composition for injection |
| 02/24/2010 | CN101653411A Controlled release hydrocodone formulations |
| 02/24/2010 | CN101653410A Lacidipine sustained-release preparation and preparation process thereof |
| 02/24/2010 | CN100591721C Poloxamer emulsion preparations |
| 02/24/2010 | CN100591357C Crosslinkable skin care adhesive |
| 02/24/2010 | CN100591356C Compositions containing nicorandil, preparation method and use |
| 02/24/2010 | CN100591354C Treatment of ophthalmic conditions |
| 02/24/2010 | CN100591333C Stable eye lotion containing latanoprost as active ingredient |
| 02/24/2010 | CN100591330C Freezing-dried clofarabine powder injection and its preparation method |
| 02/24/2010 | CN100591329C Montelukast granule formulation |
| 02/24/2010 | CN100591320C Stable surfactant compositions for suspending components |
| 02/23/2010 | USRE41148 Comprising an immediate-release component and an enteric delayed-release component; amphetamine aspartate and sulfate salts, dextroamphetamine saccharate or sulfate salts; FDA listed patent for Adderall XR 10 |
| 02/23/2010 | US7668603 Medical composition employing nanostructures |
| 02/23/2010 | US7667070 Phosphoramide type cationic lipid compounds such as 3-[[bis(tetradecyloxy)phosphoryl](methyl)amino]-N,N,N-trimethyl-propanaminium iodide; use as nonviral vectors for gene transfer |
| 02/23/2010 | US7667008 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 02/23/2010 | US7666941 Aqueous polyolefin resin dispersion, process for producing the same, and water-based coating material comprising the same |
| 02/23/2010 | US7666914 Topical preparation and method for transdermal delivery and localization of therapeutic agents |
| 02/23/2010 | US7666911 Self assembled nanostructures and methods for preparing the same |
| 02/23/2010 | US7666910 Locating an artery which carries major blood supply to the tumor; intra-arterially injecting into the located artery a predetermined quantity of a polyunsaturated fatty acid solution and anti-antiogenic substances |
| 02/23/2010 | US7666876 Buprenorphine formulations for intranasal delivery |
| 02/23/2010 | US7666860 Melt-formulated, multi-particulate oral dosage form |
| 02/23/2010 | US7666858 Pharmaceutical composition for treatment of phimosis using topical corticosteroid |
| 02/23/2010 | US7666844 Dry mouldable drug formulation |
| 02/23/2010 | US7666675 Hair follicle stem cells for use in the treatment of nervous system disorders and cell therapy |
| 02/23/2010 | US7666674 Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo |
| 02/23/2010 | US7666657 Method for production of arachidonic acid |